ocedurenone formerly known nonsteroidal selective mineralocorticoid receptor antagonist developed treat hypertension patients chronic kidney disease less risk hyperkalemia existing kpb biosciences entered talks sell drug novo nordisk billion small molecule drug administered orally phase iii trial scheduled complete httpsenwikipediaorgwikiocedurenone